6MCF

Solution structure of 7SK stem-loop 1 with HIV-1 Tat RNA Binding Domain


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the least restraint violations 

wwPDB Validation 3D Report Full Report


This is version 1.1 of the entry. See complete history

Literature

HIV-1 Tat interactions with cellular 7SK and viral TAR RNAs identifies dual structural mimicry.

Pham, V.V.Salguero, C.Khan, S.N.Meagher, J.L.Brown, W.C.Humbert, N.de Rocquigny, H.Smith, J.L.D'Souza, V.M.

(2018) Nat Commun 9: 4266-4266

  • DOI: 10.1038/s41467-018-06591-6
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 
  • The HIV Tat protein competes with the 7SK:HEXIM interaction to hijack pTEFb from 7SK snRNP and recruit it to the TAR motif on stalled viral transcripts. Here we solve structures of 7SK stemloop-1 and TAR in complex with Tat's RNA binding domain (RBD) ...

    The HIV Tat protein competes with the 7SK:HEXIM interaction to hijack pTEFb from 7SK snRNP and recruit it to the TAR motif on stalled viral transcripts. Here we solve structures of 7SK stemloop-1 and TAR in complex with Tat's RNA binding domain (RBD) to gain insights into this process. We find that 7SK is peppered with arginine sandwich motifs (ASM)-three classical and one with a pseudo configuration. Despite having similar RBDs, the presence of an additional arginine, R52, confers Tat the ability to remodel the pseudo configuration, required for HEXIM binding, into a classical sandwich, thus displacing HEXIM. Tat also uses R52 to remodel the TAR bulge into an ASM whose structure is identical to that of the remodeled ASM in 7SK. Together, our structures reveal a dual structural mimicry wherein viral Tat and TAR have co-opted structural motifs present in cellular HEXIM and 7SK for productive transcription of its genome.


    Organizational Affiliation

    Department of Pharmacy, East West University, Dhaka, 1212, Bangladesh.,Faculté de Pharmacie, Laboratoire de Bioimagerie et Pathologies, UMR 7021 du CNRS, Université de Strasbourg, 74 route du Rhin, 67401, Illkirch, France.,Vice Presidency of Research, Universidad de los Andes, Bogotá, 111711, Colombia.,Inserm - U1259 MAVIVH. Morphogenèse et Antigénicité du VIH et des Virus des Hépatites, 10 boulevard Tonnelle - BP 3223, 37032, Tours Cedex 1, France.,Department of Biological Chemistry, University of Michigan, Ann Arbor, MI, 48109, USA.,Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, 02138, USA. dsouza@mcb.harvard.edu.,Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA, 02138, USA.,Life Sciences Institute, University of Michigan, 210 Washtenaw Ave, Ann Arbor, MI, 48109, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure


Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
Protein Tat
B
17Human immunodeficiency virus type 1 group M subtype B (isolate HXB2)Mutation(s): 0 
Gene Names: tat
Find proteins for P04608 (Human immunodeficiency virus type 1 group M subtype B (isolate HXB2))
Go to UniProtKB:  P04608
Entity ID: 1
MoleculeChainsLengthOrganism
7SK Stem-loop 1 RNAA57Homo sapiens
Small Molecules
Modified Residues  1 Unique
IDChainsTypeFormula2D DiagramParent
RY
Query on RY
A
RNA linkingC9 H16 N3 O8 P

--

Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 10 
  • Selection Criteria: structures with the least restraint violations 

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)United StatesGM103297-01
Howard Hughes Medical Institute (HHMI)United States55108516

Revision History 

  • Version 1.0: 2018-10-31
    Type: Initial release
  • Version 1.1: 2019-11-20
    Type: Author supporting evidence, Data collection